# Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis

> **NCT04243681** · PHASE4 · COMPLETED · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 5 (actual)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **COMBINATION_PRODUCT:** CD 34 and MSC infusion
- **DRUG:** Standard of care for Cirrhosis management

## Key facts

- **NCT ID:** NCT04243681
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243681, "Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04243681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*